Skip to main content
Erschienen in: Osteoporosis International 8/2018

03.05.2018 | Letter

Reply to “At what price decreased mortality risk?”

verfasst von: K.L. Ong, D.P. Beall, M. Frohbergh, E. Lau, J.A. Hirsch

Erschienen in: Osteoporosis International | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Excerpt

Rodriguez and Ebeling provide thoughtful comments regarding our study [1]. They agreed with the well-documented fact that fewer augmentations were done following publication of the 2009 “sham” trials [2]. Moreover, they acknowledged the resultant elevated mortality risk in VCF patients from 2010 to 2014. We agree with their statement that it is “alarming though that the reductions in mortality risks in the post-2009 (sham trials) era were attenuated.” …
Literatur
1.
Zurück zum Zitat Ong KL, Beall DP, Frohbergh M, Lau E, Hirsch JA (2018) Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int 29(2):375–383CrossRefPubMed Ong KL, Beall DP, Frohbergh M, Lau E, Hirsch JA (2018) Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int 29(2):375–383CrossRefPubMed
2.
Zurück zum Zitat Hirsch JA, Chandra RV, Pampati V, Barr JD, Brook AL, Manchikanti L (2016) Analysis of vertebral augmentation practice patterns: a 2016 update. J Neurointerv Surg 8:1299–1304CrossRefPubMed Hirsch JA, Chandra RV, Pampati V, Barr JD, Brook AL, Manchikanti L (2016) Analysis of vertebral augmentation practice patterns: a 2016 update. J Neurointerv Surg 8:1299–1304CrossRefPubMed
3.
Zurück zum Zitat Edidin AA, Ong KL, Lau E, Schmier JK, Kemner JE, Kurtz SM (2012) Cost-effectiveness analysis of treatments for vertebral compression fractures. Appl Health Econ Health Policy 10(4):273–284CrossRefPubMed Edidin AA, Ong KL, Lau E, Schmier JK, Kemner JE, Kurtz SM (2012) Cost-effectiveness analysis of treatments for vertebral compression fractures. Appl Health Econ Health Policy 10(4):273–284CrossRefPubMed
4.
Zurück zum Zitat Ong KL, Lau E, Kemner JE, Kurtz SM (2013) Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading? Osteoporos Int 24(4):1437–1445CrossRefPubMed Ong KL, Lau E, Kemner JE, Kurtz SM (2013) Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading? Osteoporos Int 24(4):1437–1445CrossRefPubMed
5.
Zurück zum Zitat Lau E, Ong K, Kurtz S, Schmier J, Edidin A (2008) Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am 90(7):1479–1486CrossRefPubMed Lau E, Ong K, Kurtz S, Schmier J, Edidin A (2008) Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am 90(7):1479–1486CrossRefPubMed
6.
Zurück zum Zitat Chen AT, Cohen DB, Skolasky RL (2013) Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the medicare population. J Bone Joint Surg Am 95(19):1729–1736CrossRefPubMed Chen AT, Cohen DB, Skolasky RL (2013) Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the medicare population. J Bone Joint Surg Am 95(19):1729–1736CrossRefPubMed
7.
Zurück zum Zitat Edidin AA, Ong KL, Lau E, Kurtz SM (2011) Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population. J Bone Miner Res 26(7):1617–1626CrossRefPubMed Edidin AA, Ong KL, Lau E, Kurtz SM (2011) Mortality risk for operated and nonoperated vertebral fracture patients in the medicare population. J Bone Miner Res 26(7):1617–1626CrossRefPubMed
8.
Zurück zum Zitat Edidin AA, Ong KL, Lau E, Kurtz SM (2015) Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and nonoperative Management in the Medicare Population. Spine (Phila Pa 1976) 40(15):1228–1241CrossRef Edidin AA, Ong KL, Lau E, Kurtz SM (2015) Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and nonoperative Management in the Medicare Population. Spine (Phila Pa 1976) 40(15):1228–1241CrossRef
9.
Zurück zum Zitat Lange A, Kasperk C, Alvares L, Sauermann S, Braun S (2014) Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine (Phila Pa 1976) 39(4):318–326CrossRef Lange A, Kasperk C, Alvares L, Sauermann S, Braun S (2014) Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine (Phila Pa 1976) 39(4):318–326CrossRef
10.
Zurück zum Zitat McCullough BJ, Comstock BA, Deyo RA, Kreuter W, Jarvik JG (2013) Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Intern Med 173(16):1514–1521CrossRefPubMedPubMedCentral McCullough BJ, Comstock BA, Deyo RA, Kreuter W, Jarvik JG (2013) Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Intern Med 173(16):1514–1521CrossRefPubMedPubMedCentral
Metadaten
Titel
Reply to “At what price decreased mortality risk?”
verfasst von
K.L. Ong
D.P. Beall
M. Frohbergh
E. Lau
J.A. Hirsch
Publikationsdatum
03.05.2018
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 8/2018
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4551-4

Weitere Artikel der Ausgabe 8/2018

Osteoporosis International 8/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.